{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T02:32:27Z","timestamp":1772764347694,"version":"3.50.1"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000156","name":"Quebec Health Research Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000156","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuromuscular Disorders"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.nmd.2025.105386","type":"journal-article","created":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T06:31:36Z","timestamp":1747377096000},"page":"105386","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Clinical pearls and histopathological features help discriminate toxic rhabdomyolysis from immune-mediated necrotizing myopathy in statin-exposed patients"],"prefix":"10.1016","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8716-7924","authenticated-orcid":false,"given":"Benjamin","family":"Ellezam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yves","family":"Troyanov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oc\u00e9ane","family":"Landon-Cardinal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nmd.2025.105386_bib0001","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1002\/art.30156","article-title":"Autoantibodies against 3-hydroxy-3-methylglutaryl-coenzyme A reductase in patients with statin-associated autoimmune myopathy","volume":"63","author":"Mammen","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.nmd.2025.105386_bib0002","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1002\/art.27572","article-title":"A novel autoantibody recognizing 200-kd and 100-kd proteins is associated with an immune-mediated necrotizing myopathy","volume":"62","author":"Christopher-Stine","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.nmd.2025.105386_bib0003","doi-asserted-by":"crossref","first-page":"e523","DOI":"10.1212\/NXI.0000000000000523","article-title":"Anti-HMGCR myopathy may resemble limb-girdle muscular dystrophy","volume":"6","author":"Mohassel","year":"2019","journal-title":"Neurol - Neuroimmunol Neuroinflammat"},{"key":"10.1016\/j.nmd.2025.105386_bib0004","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s13075-019-2093-6","article-title":"Statin-induced anti-HMGCR myopathy: successful therapeutic strategies for corticosteroid-free remission in 55 patients","volume":"22","author":"Meyer","year":"2020","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.nmd.2025.105386_bib0005","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/s41584-020-00515-9","article-title":"Immune-mediated necrotizing myopathy: clinical features and pathogenesis","volume":"16","author":"Allenbach","year":"2020","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.nmd.2025.105386_bib0006","first-page":"150","article-title":"Anti-HMGCR autoantibodies in European patients with autoimmune necrotizing myopathies: inconstant exposure to statin","volume":"93","author":"Allenbach","year":"2014","journal-title":"Medinice"},{"key":"10.1016\/j.nmd.2025.105386_bib0007","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1002\/mus.24606","article-title":"Diagnostic evaluation of rhabdomyolysis","volume":"51","author":"Nance","year":"2015","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2025.105386_bib0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.disamonth.2020.101015","volume":"66","author":"Cabral","year":"2020","journal-title":"Dis Mon"},{"key":"10.1016\/j.nmd.2025.105386_bib0009","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jbspin.2019.01.018","article-title":"Statins, myalgia, and rhabdomyolysis","volume":"87","author":"Tournadre","year":"2020","journal-title":"Jt Bone Spine"},{"key":"10.1016\/j.nmd.2025.105386_bib0010","doi-asserted-by":"crossref","first-page":"381","DOI":"10.2217\/pgs-2023-0043","article-title":"The frequency of major ABCG2, SLCO1B1 and CYP2C9 variants in Asian, Native Hawaiian and Pacific Islander women subgroups: implications for personalized statins dosing","volume":"24","author":"Alrajeh","year":"2023","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.nmd.2025.105386_bib0011","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1007\/s00415-019-09185-4","article-title":"A systematic review on the definition of rhabdomyolysis","volume":"267","author":"Stahl","year":"2020","journal-title":"J Neurol"},{"key":"10.1016\/j.nmd.2025.105386_bib0012","doi-asserted-by":"crossref","first-page":"e1763","DOI":"10.1212\/WNL.0000000000007260","article-title":"Immune myopathy with large histiocyte-related myofiber necrosis","volume":"92","author":"Pestronk","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2025.105386_bib0013","series-title":"Toxic And Drug-Induced Myopathies. Muscle Biopsy: A Practical Approach","first-page":"502","author":"Dubowitz","year":"2021"},{"key":"10.1016\/j.nmd.2025.105386_bib0014","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241612545","article-title":"Regenerating myofibers after an acute muscle injury: what do we really know about them?","volume":"24","author":"Pizza","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.nmd.2025.105386_bib0015","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/aja.1001370202","article-title":"The regeneration of skeletal muscle. A review","volume":"137","author":"Carlson","year":"1973","journal-title":"Am J Anat"},{"key":"10.1016\/j.nmd.2025.105386_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2021.102851","article-title":"Histopathological features of systemic sclerosis-associated myopathy: a scoping review","volume":"20","author":"Lefebvre","year":"2021","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.nmd.2025.105386_bib0017","doi-asserted-by":"crossref","DOI":"10.1111\/nan.12840","article-title":"Capillary pathology with prominent basement membrane reduplication is the hallmark histopathological feature of scleromyositis","volume":"48","author":"Ellezam","year":"2022","journal-title":"Neuropathol Appl Neurobiol"},{"key":"10.1016\/j.nmd.2025.105386_bib0018","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1097\/WCO.0b013e328364e9d9","article-title":"Acquired necrotizing myopathies","volume":"26","author":"Allenbach","year":"2013","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.nmd.2025.105386_bib0019","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/bpa.12772","article-title":"Sequestosome-1 (p62) expression reveals chaperone-assisted selective autophagy in immune-mediated necrotizing myopathies","volume":"30","author":"Fischer","year":"2020","journal-title":"Brain Pathol"},{"key":"10.1016\/j.nmd.2025.105386_bib0020","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/mus.27739","article-title":"Autophagy in non-immune-mediated rhabdomyolysis: assessment of p62 immunohistochemistry","volume":"67","author":"Acosta","year":"2023","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2025.105386_bib0021","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1159\/000116845","article-title":"Lovastatin\/gemfibrozil myopathy: a clinical, histochemical, and ultrastructural study","volume":"32","author":"Chucrallah","year":"1992","journal-title":"Eur Neurol"},{"key":"10.1016\/j.nmd.2025.105386_bib0022","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1097\/00131402-200206000-00002","article-title":"Myopathy associated with HMG-CoA reductase inhibitors (Statins): a series of 10 patients and review of the literature","volume":"3","author":"McKelvie","year":"2002","journal-title":"J Clin Neuromuscul Dis"},{"key":"10.1016\/j.nmd.2025.105386_bib0023","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1016\/j.ajpath.2012.08.033","article-title":"Immune-mediated necrotizing myopathy is characterized by a specific Th1-M1 polarized immune profile","volume":"181","author":"Preusse","year":"2012","journal-title":"Am J Pathol"},{"key":"10.1016\/j.nmd.2025.105386_bib0024","doi-asserted-by":"crossref","first-page":"e507","DOI":"10.1212\/WNL.0000000000004923","article-title":"Necrosis in anti-SRP+ and anti-HMGCR+ myopathies: role of autoantibodies and complement","volume":"90","author":"Allenbach","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2025.105386_bib0025","series-title":"Muscle Biopsy: A Practical Approach","first-page":"46","article-title":"Histological and histochemical changes","author":"Dubowitz","year":"2021"},{"key":"10.1016\/j.nmd.2025.105386_bib0026","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1146\/annurev-pathmechdis-012419-032618","article-title":"Autophagy defects in skeletal myopathies","volume":"15","author":"Margeta","year":"2020","journal-title":"Annu Rev Pathol"},{"key":"10.1016\/j.nmd.2025.105386_bib0027","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1056\/NEJM197410172911601","article-title":"Nontraumatic rhabdomyolysis and acute renal failure","volume":"291","author":"Grossman","year":"1974","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nmd.2025.105386_bib0028","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1056\/NEJMra0801327","article-title":"Rhabdomyolysis and acute kidney injury","volume":"361","author":"Bosch","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nmd.2025.105386_bib0029","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/01.md.0000188565.48918.41","article-title":"Rhabdomyolysis: an evaluation of 475 hospitalized patients","volume":"84","author":"Melli","year":"2005","journal-title":"Medicine"},{"key":"10.1016\/j.nmd.2025.105386_bib0030","first-page":"33","article-title":"The spectrum of renal involvement in patients with inflammatory myopathies","volume":"93","author":"Couvrat-Desvergnes","year":"2014","journal-title":"Medince"},{"key":"10.1016\/j.nmd.2025.105386_bib0031","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1136\/annrheumdis-2016-210198","article-title":"Thigh muscle MRI in immune-mediated necrotising myopathy: extensive oedema, early muscle damage and role of anti-SRP autoantibodies as a marker of severity","volume":"76","author":"Pinal-Fernandez","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.nmd.2025.105386_bib0032","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1007\/s00415-022-11447-7","article-title":"Muscle MRI in immune-mediated necrotizing myopathy (IMNM): implications for clinical management and treatment strategies","volume":"270","author":"Fionda","year":"2023","journal-title":"J Neurol"},{"key":"10.1016\/j.nmd.2025.105386_bib0033","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1016\/j.semarthrit.2020.02.009","article-title":"Severe axial and pelvifemoral muscle damage in immune-mediated necrotizing myopathy evaluated by whole-body MRI","volume":"50","author":"Landon-Cardinal","year":"2020","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.nmd.2025.105386_bib0034","doi-asserted-by":"crossref","DOI":"10.1002\/jimd.12781","article-title":"Cellular mechanisms of acute rhabdomyolysis in inherited metabolic diseases","volume":"48","author":"de Calbiac","year":"2025","journal-title":"J Inherit Metab Dis"}],"container-title":["Neuromuscular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896625001130?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896625001130?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T23:24:25Z","timestamp":1750375465000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960896625001130"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":34,"alternative-id":["S0960896625001130"],"URL":"https:\/\/doi.org\/10.1016\/j.nmd.2025.105386","relation":{},"ISSN":["0960-8966"],"issn-type":[{"value":"0960-8966","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical pearls and histopathological features help discriminate toxic rhabdomyolysis from immune-mediated necrotizing myopathy in statin-exposed patients","name":"articletitle","label":"Article Title"},{"value":"Neuromuscular Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nmd.2025.105386","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"105386"}}